Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Direct acting antiviral treatment of chronic hepatitis C in Denmark: factors associated with and barriers to treatment initiation

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Long term treatment with stimulant laxatives - clinical evidence for effectiveness and safety?

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Antibiotics: a risk factor for irritable bowel syndrome in a population-based cohort

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Quality of life, performance status, and work capacity after post-endoscopic retrograde cholangiopancreatography pancreatitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Microscopic colitis in Denmark and Sweden: incidence, putative risk factors, histological assessment and endoscopic activity

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Nutritional status and nutritional risk in patients with neuroendocrine tumors

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Hypervariable region 1 and N-linked glycans of hepatitis C regulate virion neutralization by modulating envelope conformations

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Children Attending Day Care Centers are a Year-round Reservoir of Gastrointestinal Viruses

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. HCV genotype 1-6 NS3 residue 80 substitutions impact protease inhibitor activity and promote viral escape

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
AbstractObjectives: We describe factors associated with and barriers to initiation of Direct Acting Antiviral (DAA) treatment in patients with chronic hepatitis C, who fulfill national fibrosis treatment guidelines in Denmark.Materials and Methods: In this nationwide cohort study, we included patients with chronic hepatitis C from The Danish Database for Hepatitis B and C (DANHEP) who fulfilled fibrosis treatment criteria. Factors associated with treatment initiation and treatment failure were determined by logistic regression analyses. Medical records were reviewed from patients who fulfilled fibrosis treatment criteria, but did not initiate DAA treatment to determine the cause.Results: In 344 (49%) of 700 patients, who fulfilled treatment criteria, factors associated with DAA treatment initiation were transmission by other routes than injecting drug use odds ratio (OR) 2.13 (CI: 1.38–3.28), previous treatment failure OR 2.58 (CI: 1.84–3.61) and ALT above upper limit of normal OR 1.60 (CI: 1.18–2.17). Th...
OriginalsprogEngelsk
TidsskriftScandinavian Journal of Gastroenterology
Vol/bind53
Udgave nummer7
Sider (fra-til)849-856
ISSN0036-5521
DOI
StatusUdgivet - 1 maj 2018

    Forskningsområder

  • DAA,Direct Acting Antivirals,HCV,barriers to treatment,factors associated with treatment,hepatitis C virus,liver cancer,liver disease,treatment initiation

ID: 54945681